These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 1648690)
1. Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation. Benoliel JJ; Bourgoin S; Mauborgne A; Legrand JC; Hamon M; Cesselin F Neurosci Lett; 1991 Apr; 124(2):204-7. PubMed ID: 1648690 [TBL] [Abstract][Full Text] [Related]
2. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079 [TBL] [Abstract][Full Text] [Related]
3. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648 [TBL] [Abstract][Full Text] [Related]
4. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release. Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026 [TBL] [Abstract][Full Text] [Related]
5. Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. Mauborgne A; Lutz O; Legrand JC; Hamon M; Cesselin F J Neurochem; 1987 Feb; 48(2):529-37. PubMed ID: 2432185 [TBL] [Abstract][Full Text] [Related]
6. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors. Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822 [TBL] [Abstract][Full Text] [Related]
7. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra. Benoliel JJ; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F J Neurochem; 1992 Mar; 58(3):916-22. PubMed ID: 1310726 [TBL] [Abstract][Full Text] [Related]
8. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord. Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527 [TBL] [Abstract][Full Text] [Related]
9. Identification of opioid receptors on gastric muscle cells by selective receptor protection. Grider JR; Makhlouf GM Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978 [TBL] [Abstract][Full Text] [Related]
10. Opioid-receptor-mediated inhibition of [3H]dopamine but not [3H]noradrenaline release from rat mediobasal hypothalamus slices. Heijna MH; Padt M; Hogenboom F; Schoffelmeer AN; Mulder AH Neuroendocrinology; 1991 Aug; 54(2):118-26. PubMed ID: 1662785 [TBL] [Abstract][Full Text] [Related]
11. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485 [TBL] [Abstract][Full Text] [Related]
12. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
13. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat. Miaskowski C; Taiwo YO; Levine JD Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910 [TBL] [Abstract][Full Text] [Related]
14. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices. Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278 [TBL] [Abstract][Full Text] [Related]
15. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782 [TBL] [Abstract][Full Text] [Related]
16. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat. Yuan CS Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215 [TBL] [Abstract][Full Text] [Related]
17. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock. Feuerstein G; Powell E; Faden AI Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939 [TBL] [Abstract][Full Text] [Related]
18. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat. Hope PJ; Fleetwood-Walker SM; Mitchell R Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238 [TBL] [Abstract][Full Text] [Related]
19. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy. Gustafsson H; Afrah AW; Stiller CO J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973 [TBL] [Abstract][Full Text] [Related]
20. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]